Results 11 to 20 of about 277,876 (250)

Overview of Graves Ophthalmopathy Literature From 1999 to 2019: Bibliometric Analysis

Interactive Journal of Medical Research, 2021
BackgroundResearch on Graves ophthalmopathy has increased remarkably over the last 2 decades; however, few statistical analyses of the data presented in these publications have been conducted.
Jiamin Cao, Nuo Wang, Shiying Hou, Xin Qi, Yu Chen, Wei Xiong   +5 more
doaj   +2 more sources

Research progress on the pathogenesis of Graves’ ophthalmopathy: Based on immunity, noncoding RNA and exosomes

Frontiers in Immunology, 2022
Graves’ ophthalmopathy (GO), also known as thyroid-associated ophthalmopathy, is a common potentially vision-threatening organ-specific autoimmune disease and the most common extrathyroidal manifestation of Graves’ disease.
Jingyi Zheng, Jingyi Zheng, Honghong Duan, Sufang You, Sufang You, Bo Liang, Yuping Chen, Yuping Chen, Huibin Huang   +8 more
doaj   +2 more sources

Analysis of Foveal and Parafoveal Microvascular Density and Retinal Vessel Caliber Alteration in Inactive Graves’ Ophthalmopathy

Journal of Ophthalmology, 2020
Purpose. We aimed to evaluate foveal and parafoveal density using optical coherence tomography angiography and the alteration on the retinal vessel diameter in patients with inactive Graves’ ophthalmopathy compared to age-matched normal population ...
Cetin Akpolat, Muhammed M. Kurt, Merve Yılmaz, Fikriye Ordulu, Ferhat Evliyaoglu   +4 more
doaj   +2 more sources

Current and Future Treatments for Graves’ Disease and Graves’ Ophthalmopathy [PDF]

Hormone and Metabolic Research, 2018
The course and pathogenesis of Graves’ disease and Graves’ ophthalmopathy are interdependent, influencing each other’s therapeutic choices. Multiple factors including geographic location, access to medical services, patient and physician preferences ...
Anupam Kotwal, Marius N. Stan
openalex   +2 more sources

Ocular surface changes in Graves’ ophthalmopathy

International Journal of Ophthalmology, 2021
Many patients with Graves' ophthalmopathy (GO) suffer from dry eye syndrome (DES), and this is one of the most common reasons of eye discomfort in patients with GO.
Rou Sun, Huifang Zhou
openalex   +2 more sources

TSHR-Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition. [PDF]

Adv Sci (Weinh)
This study presents YC3, a novel inhibitory TSHR‐targeting aptamer, as a promising therapeutic for Graves' ophthalmopathy (GO). YC3 suppresses pathological phenotypes in human orbital fibroblasts and improves outcomes in GO mice by binding to a previously unidentified allosteric site on TSHR, demonstrating the potential of aptamers in advancing ...
Zhang Y, Wu E, Liu W, Zeng L, Ling N, Wang H, Li Z, Yao S, Pan T, Li X, Huang Y, Li X, Tu Y, Yan W, Wu J, Ye M, Wu W.   +16 more
europepmc   +2 more sources

A Case of Thyrotoxic Periodic Paralysis and Graves’ Ophthalmopathy Patient in Coincidence with Chronic Hepatitis B Infection

The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022
Graves' disease is an autoimmune thyroid disease with several characteristic symptoms and signs. Graves' ophthalmopathy, an inflammatory disease in the orbital area, is the main extrathyroid manifestation of Graves' disease.
Herry Krisnata Ginting, Soebagijo Adi
doaj   +1 more source

Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy

Journal of Magnetic Resonance Imaging, 2023
Assessment of the activity of Graves' ophthalmopathy (GO) is difficult. Existing methods need improvement.
Zhangfang Li, Yaosheng Luo, Xiaoting Feng, Qing Zhang, Qiang Zhong, Chanyan Weng, Zhi Chen, Jie Shen   +7 more
semanticscholar   +1 more source

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy

Frontiers in Endocrinology, 2022
Graves’ Ophthalmopathy (GO) is an organ-specific autoimmune disease that is often characterized by infiltration of orbital tissues and is considered as the most common extra-thyroid manifestation of Graves’ disease (GD).
Yan Wang, Xiao-Min Ma, Xin Wang, Xin Sun, Ling Wang, Xin-Qi Li, Xiaoyang Liu, Hongyang Yu   +7 more
semanticscholar   +1 more source

Current insights of applying MRI in Graves’ ophthalmopathy

Frontiers in Endocrinology, 2022
Graves’ ophthalmopathy (GO) is an autoimmune disease related to Grave’s disease (GD). The therapeutic strategies for GO patients are based on precise assessment of the activity and severity of the disease.
C. Song, Yaosheng Luo, Gaofeng Yu, Haixiong Chen, Jie Shen   +4 more
semanticscholar   +1 more source